Keyphrases
1-year Survival
14%
Advanced Ovarian Cancer
21%
Advanced Stage
24%
Aldehyde Dehydrogenase 2 (ALDH2)
16%
Cancer Stage
18%
Cancer Stem Cell Markers
12%
Cervical Cancer
100%
Cervical Cancer Patients
33%
Cervical Squamous Cell Carcinoma
21%
Cluster of Differentiation 44 (CD44)
12%
Complete Response
15%
Disease-free Survival
17%
Enlargement
13%
Gynecological Cancer
21%
Hypoxia-inducible factor-1α (HIF-1α)
21%
Immune Checkpoint Inhibitors
21%
Indonesia
56%
Indonesian
23%
Jakarta
31%
Knowledge Attitude
21%
Knowledge Practices
21%
Lymph Node Enlargement
21%
Median Survival
12%
Meta-analysis
12%
Meta-analysis of Randomized Controlled Trials
21%
Negative Reactivity
11%
Obstetrics and Gynaecology
13%
Odds Ratio
16%
Ovarian Cancer Patients
23%
Overall Survival
17%
Pada
16%
Papillomavirus Infections
21%
Patient-reported Outcomes
21%
Radiation Therapy
21%
Radiotherapy
37%
Radiotherapy Outcome
17%
Response Predictors
21%
Safety Self-efficacy
21%
Socio-demographic Profile
12%
Squamous Cell Carcinoma (SqCC)
21%
Squamous Cell Cervical Carcinoma
10%
Surgical Outcomes
12%
Survivin
25%
Sustainable Development Goals
21%
Systematic Meta-analysis
32%
Telomerase
21%
Tumor Size
13%
Urban Community
21%
Visual Inspection with Acetic Acid
15%
Young Age
11%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
10%
Acetic Acid
15%
Biopsy Technique
11%
Cancer
16%
Cancer Staging
12%
Cancer Stem Cell
16%
Caspase 3
10%
Cell Marker
13%
Cervical Cancer
96%
Cervix
24%
Community Health
10%
Cross Sectional Study
20%
Cytoreductive Surgery
14%
Debulking Surgery
14%
Deep Vein Thrombosis
10%
Diabetes Mellitus
10%
Disease Free Survival
16%
Endometrium
10%
Endometrium Carcinoma
10%
Female Genital Tract Cancer
21%
Hypoxia Inducible Factor 1
10%
Immune Checkpoint Inhibitor
21%
Insulin Resistance
10%
Krukenberg Tumor
32%
Lymphadenopathy
21%
Malignant Neoplasm
19%
Meta-Analysis
32%
Metastatic Carcinoma
11%
Neoplasm
23%
Neuroendocrine Carcinoma
10%
Ovarian Cancer
21%
Ovarian Tumor
11%
Overall Survival
16%
Papillomavirus Infection
10%
Paraaortic Lymph Node
10%
Patient-Reported Outcome
21%
Radiation Therapy
68%
Randomized Controlled Trial
21%
Skin Metastasis
10%
Squamous Cell
32%
Squamous Cell Carcinoma
37%
Survival Rate
18%
Survivin
32%
Systematic Review
32%
Telomerase
21%
Tobacco Use
10%
Urban Population
10%
Uterine Cervix
10%
Uterine Cervix Carcinoma
10%
Uterine Cervix Cytology
10%